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Notoriously chemoresistant melanoma has become the most prevalent form of cancer for the 25–29 North American age
demographic.Standardtreatmentafterearlydetectioninvolvessurgicalexcision(recurrenceispossible),andmetastaticmelanoma
is refractory to immuno-, radio-, and most harmful chemotherapies. Various natural compounds have shown eﬃcacy in killing
diﬀerent cancers, albeit not always speciﬁcally. In this study, we show that dandelion root extract (DRE) speciﬁcally and eﬀectively
inducesapoptosisinhumanmelanomacellswithoutinducingtoxicityinnoncancerouscells.Characteristicapoptoticmorphology
of nuclear condensation and phosphatidylserine ﬂipping to the outer leaﬂet of the plasma membrane of A375 human melanoma
cells was observed within 48 hours. DRE-induced apoptosis activates caspase-8 in A375 cells early on, demonstrating employment
of an extrinsic apoptotic pathway to kill A375 cells. Reactive Oxygen Species (ROS) generated from DRE-treated isolated
mitochondria indicates that natural compounds in DRE can also directly target mitochondria. Interestingly, the relatively resistant
G361 human melanoma cell line responded to DRE when combined with the metabolism interfering antitype II diabetic drug
metformin. Therefore, treatment with this common, yet potent extract of natural compounds has proven novel in speciﬁcally
inducing apoptosis in chemoresistant melanoma, without toxicity to healthy cells.
1.Introduction
Melanoma skin cancer is among one of the leading cancers
targetingadolescentsandyoungadultsintheNorthAmerica.
Melanoma is notoriously chemo-resistant and the modes of
treatment for melanoma are very limited, relying mainly on
surgical excision of the primary site during early detection,
and whatever limited chemotherapy and immunotherapy
for metastasized melanoma that is available. However, these
therapies have limited success and incur side eﬀects [1].
Taraxacum Oﬃcinale is most commonly known as dan-
delion. Regarded as a regular garden weed, this detoxifying
herb has long been used in traditional Chinese medicine,
for ailments ranging from digestive disorders to complex
disorders such as uterine, breast and lung tumours [2].
Traditional Middle Eastern remedies require dandelions for
spleen and liver ailments, while Native Americans have
harnessed their properties to cure indigestion, heartburn,
and kidney disease [2, 3]. Dandelion plants were (Taraxacum
oﬃcinale Weber ex Wiggers) were used by East Indians in
the 16 century as a hepatic stimulant, diuretic, for liver
disorders, and most interestingly, for chronic skin diseases
[4, 5]. These roots are a source of triterpenes and steroids
[4, 6]. Hata et al. found that upon screening a variety
of compounds from wild plants, Taraxacum Oﬃcinale was
an eﬀective inducer of diﬀerentiation in mouse melanoma
cells. Furthermore, this group found that one constituent
of Chinese dandelion, Lupeol-a triterpene, up-regulated
melanogenesis and decreased cell proliferation in mouse
melanoma [7]. This triterpene is regarded as cytostatic and
notcytotoxic.Inanotherstudy,skintumourswerepromoted
in vivo in mice through a two-stage chemical carcinogenesis
and treated with water and methanol extracts of Taraxacum
japonicum. This showed inhibition of tumour initiation
and promotion at both carcinogenesis stages, and it was
concludedthatTaraxacum,andmorespeciﬁcallytaraxasterol
(a triterpenoid), is a worthy chemopreventative agent [8, 9].
More recently, Jeon et al. have shown that ethanolic
Taraxacum Oﬃcinale extracts and derivative forms thereof
reduce levels of reactive oxygen species (ROS) and nitric
oxide production (NO) and inhibit COX-2 expression or
its antioxidant activity, thus making dandelion extracts2 Evidence-Based Complementary and Alternative Medicine
not only anti-carcinogenic, but anti-inﬂammatory, antian-
giogenic and also antinociceptive [10]. Dandelion ﬂower
extracts (DFE) were tested on RAW264.7 cells (mouse
macrophages) and exhibited inhibition of NO production in
these noncancerous cells. The inhibition of reactive nitrogen
species (RNS) as well as ROS by DFE was attributed to its
phenolic components [11]. Sigstedt et al. tested aqueous
DFE, dandelion leaf extract (DLE), and dandelion root
extract (DRE), from Taraxacum Oﬃcinale,o nav a r i a n t
MCF-7 breast cancer cell line (MCF-7/AZ) and LNCaP
prostate cancer line. While DLE inhibited cell proliferation
in MCF-7/AZ, DFE and DRE did not. However, DRE and
DLE blocked invasion of MCF-7/AZ and LNCaP cells (into
collagen type I), respectively. Inhibition of cell invasion was
corroboratedbyreducedmatrixmetalloproteinaseactivityof
MMP-2 and -9, as well as reduced phosphorylation levels of
src and FAK [2]. Taraxacum Oﬃcinale extract was used to
treatHepG2humanhepatomacellsandwasfoundtoreduce
cell viability and induce cytotoxicity through interleukin-
α and TNF-α [12]. Regardless of the valuable traditional
knowledge of Taraxacum antitumor activity, there has been
inadequate biochemical research to apply this knowledge to
cancer cell lines and especially chemo-resistant melanoma.
Population studies have highlighted the correlation
between diabetic patients taking Metformin and a reduced
incidence of cancer and lower rates of mortality. Jiraler-
spong et al. had clinically proven this by determining that
diabetics with breast cancer taking Metformin had a higher
pathological complete response than diabetic breast cancer
patients not taking the drug [13]. Normally, healthy cells
express adenosine monophosphate-activated protein kinase
(AMPK), which is directly downstream of the tumour
suppressor LKB1 and is usually activated as a reaction to
cellular energy stress. Metformin can also activate AMPK,
leading to suppression of the ATP consuming pathways
(e.g., gluconeogenesis) and activation of the ATP generating
pathways (e.g., glycolysis). Though the mechanisms for
metformin treatment of cancer is not clearly understood; it
is clear that cancer cell energy metabolism diﬀers from that
of normal cells, and this diﬀerence makes tumourigenic cells
vulnerable to metabolism-interfering drugs like metformin
[14].
In this study, we have investigated the eﬀect of dandelion
root extract on human melanoma cell lines in vitro.F o r
melanoma, a very aggressive, chemo-resistant form of skin
cancer, we have shown that DRE has been very eﬀective in
inducing apoptosis. We have also seen that the extract targets
the mitochondria, generating reactive oxygen species. It is
possible that the compounds in the extract work through the
extrinsic apoptotic pathway, as is indicated by elevated levels
of early caspase-8 activation. We have also observed that
drug-resistant melanoma cells could be made more sensitive
to DRE treatment by the metabolism interfering drug, met-
formin. This is the ﬁrst time that a study has been performed
with metformin and human melanoma. Though it is unclear
which components of DRE are active in successfully killing
human melanoma cells, our work with Taraxacum DRE
presents a novel, natural chemotherapeutic agent that may
be extended to other chemo-resistant cancer lines.
2.MaterialsandMethods
2.1. Cell Culture. Human melanoma cell lines, A375 and
G361, were purchased from ATCC (Manasas, VA, USA).
A375 human melanoma cells were grown and cultured
at 37◦C and 5% CO2 in RPMI-1640 media containing
L-glutamine and NaHCO3 (Sigma-Aldrich, Oakville, ON,
Canada) completed with 10% Fetal Bovine Serum (FBS)
(Sigma, Canada) and 10μg/mL gentamicin (Gibco, Canada).
G361 human melanoma cells were cultured in McCoy’s
Medium 5a modiﬁed with L-glutamine (Gibco, Canada) in
the same manner as the A375s.
Human nucleated blood cells were puriﬁed from whole
blood obtained from healthy volunteers as approved by
the University of Windsor ethical committee, REB# 04-060.
Whole blood (12mL) was collected into a BD Vacutainer
CPT Tube (Cell Preparation Tube) obtained from Becton
Dickinson (Franklin Lakes, N.J.). The whole blood was
spun down in a table-top low-speed centrifuge at 2900 ×g
for 30min at 25◦C. The red blood cells went through the
polyester gel and the top layer containing mononuclear
cells, platelets, and plasma was collected. These peripheral
mononuclear blood cells (PBMCs) were incubated at 37◦C,
5% CO2, and 95% humidity. Normal human Fibroblasts
(NHFs) were purchased from the Coriell Institute for Medi-
cal Research, USA. NHFs were cultured in Earle’s Minimum
Essential Medium (Sigma-Aldrich, Oakville, ON, Canada)
completed with 15% FBS, 2mM L-glutamine, 10μg/mL
gentamicin, vitamins, and essential and nonessential amino
acids (Gibco, Canada).
2.2. Cell Treatment. Water extracts of dandelion root were
prepared using variety of ﬁltering stages, lyophilized, con-
stituted to a particular stock concentration and sterilized.
Washed roots were blended in water until macerated. The
blended mass was then passed through a nylon mesh to ﬁlter
out very large ﬁbres. The ﬁltrate was then centrifuged at
5000g for 5 minutes at room temperature. The supernatant
was then ﬁltered through a Buchner funnel. The ﬁltrate was
then passed through a 0.45 micron ﬁlter then a 0.2 micron
ﬁlter, before being lyophilized to a ﬁne powder. The powder
is then reconstituted with sterile 1X Phosphate Buﬀer Saline
(PBS) to a particular stock concentration after which the
DRE is further diluted upon cellular treatment in media.
Cells (A375 and G361 human melanoma cells, and NHFs)
were treated with DRE at a 60% conﬂuence, at the indicated
concentrations and time points. PBMCs were grown to 70%
conﬂuence and then treated either with the freshly prepared
water extracts or with diﬀerent concentrations of lyophilized
extract (0.2mg/mL to 0.6mg/mL.
The G361 human melanoma cells were also treated with
metformin (1,1-dimethylbiguanide hydrochloride- Aldrich,
USA) at a concentration of 4mM. This concentration was
based upon work done by previous groups, which had used
concentrations ranging from 0.5 to 10mM metformin to
treat human breast carcinoma cells [15]; Isakovic et al. used
concentrations upto to 8mM to treat glioma cells [16], and
concentrations of metformin reached as high as 20mM to
inhibit mTOR in human breast carcinoma [14].Evidence-Based Complementary and Alternative Medicine 3
2.3. Cell Viability. Cell viability was measured using a WST-
1reagent (Roche Applied Science, IN, USA). A375s G361s
and NHFs were plated with a ﬁxed number of cells per well
96-well tissue culture plates. After 24 hours, the cells were
treated with DRE at the indicated concentrations. WST-1
reagent was added to the wells after the treatment period and
incubated at 37◦C for 4 hours. The plates were then read at
450nm on a Wallac Victor3 1420 Multilabel Counter (Perkin
Elmer, ON, Canada). Absorbance readings are expressed
in terms of cell viability as percent control (untreated
cells).
2.4. Cellular Staining. Cells treated with DRE for the spec-
iﬁed time periods were stained with Hoechst 33342 dye
(ﬁnal concentration 10μM) as per a previously published
protocol [17], to image the cellular morphological features.
Apoptotic cells are characterized by condensed, brightly
stained nuclei. Nonapoptotic cells are not condensed or
brightly stained. Cells were imaged with the dye using a
ﬂuorescent microscope (Leica DM IRB); pictures were taken
at 40X objective.
2.5. Annexin-V Binding Assay. To conﬁrm DRE-induced
apoptosis in, Annexin-V binding assay was performed after
48 hours with DRE using a kit and manufacturer’s protocol
(Sigma-Aldrich, Oakville, ON, Canada). Posttreatment cells
were washed twice with PBS and resuspended in Annexin-
V binding buﬀer (10mM HEPES, 10mM NaOH, 140mM
NaCl, 1mM CaCl2, pH 7.6). Annexin-V-FITC conjugate
(1:50) was added to the cells and incubated for 15 minutes
at room temperature. Cells were observed and imaged under
a ﬂuorescent microscope (Leica DM IRB); images were taken
at 40x objective.
2.6. Caspase-8 Activity Assay. Caspase activity was assayed
using a previously published protocol and manufacturer’s
procedure (Enzyme System Products, USA). Cell lysates
were prepared using A375 human melanoma cells and
incubated for 1 hour with caspase-8 ﬂuorogenic substrate
(IETD-AFC) in IETD buﬀer at 37◦C (Calbiochem) in
96-well opaque microtiter plates. AFC ﬂuorescence was
measured at 400nm excitation and 505nm emission using
spectroﬂuorometer (SpectraMax Gemini XS). Caspase activ-
ity was measured expressed in terms of per μg protein,
and protein concentration was determined using Bradford
Assay (BioRad); Bovine Serum Albumin (BSA) was used as
a standard.
2.7. Observation of Mitochondrial Membrane Potential Depo-
larization. Human melanoma A375 cells were seeded on
sterile coverslips in 6-well tissue culture plates and treated
with DRE for 24 hours. After DRE treatment, the cells were
incubated for 1 hour with JC-1 dye (5,5 ,6,6 -tetrachloro-
1,1 ,3,3 -tetraethyl-benzamidazolocarbocyanin iodide) at a
ﬁnal concentration of 0.5μMa t3 7 ◦C. Cells were observed
and imaged using a ﬂuorescent microscope (Leica DM IRB);
images were taken at 40x objective.
2.8. Measurement of Mitochondrial Reactive Oxygen Species.
Mitochondria were isolated from A375 cells based on
a previously published protocol [18]. The mitochondria
were treated directly with DRE in 96-well opaque microtiter
plates. Amplex Red (5μM) and horseradish peroxidase
(HRP) were added to the mitochondria posttreatment.
The ﬂuorescent resoruﬁn product was measured at 530nm
excitation and 580nm emission using spectroﬂuorometer
(SpectraMax Gemini XS). Relative Fluorescence Units were
measured and expressed in terms of per μg protein, and
protein concentration was determined using Bradford Assay
(BioRad);BovineSerumAlbumin(BSA)wasusedasastand-
ard.
2.9. Immunoblotting. Whole cell lysates were prepared from
treated cells and were run on 12% SDS-polyacrylamide gels.
The gels were then transferred to a nitrocellulose membrane
and probed for the proteins of interest (Bcl-2 and β-Actin-
Santa Cruz Biotechnology). The blots were then probed with
a secondary antibody conjugated to HRP and incubated,
following which they were momentarily incubated with the
chemiluminscent substrate (Sigma), before being exposed.
2.10. Posttreatment Cell Revival. A375 cells pretreated with
DRE for 72 hours were trypsinized and replated in drug-
free RPMI1640 media and incubated for 96 hours at 37◦C
and 5% CO2. Cells were stained using Hoechst 33342 dye
and imaged using a ﬂuorescent microscope (Leica DM IRB);
pictures were taken at 40x objective. Cells were also collected
and counted using Trypan blue exclusion assay.
2.11.High-PerformanceLiquidChromatography. Ahigh-per-
formance liquid chromatography (HPLC) system, obtained
from Waters Corporation (Mississauga, ON.), was used for
separation and comparative analysis of Dandelion Root
Extract (commercially available compared to that prepared
by the Pandey Lab). The system consisted of a binary HPLC
pump, an autosampler, a dual-wavelength absorbance detec-
tor, and a BDS HYPERSIL C18 reverse phase column (5μM,
150 ×4.6mm)obtainedfromThermoElectronCorporation
(Palm Beach, FL), controlled by Breeze Software. Elutions
were isocratic with a mobile phase consisting of methanol
and 0.1% acetic acid (80:20 at 230nm). The injection
volume was 10μL with a ﬂow rate of 1.0mL/min. Each
sample was run for three hours in triplicate.
3. Results
3.1. Eﬀect of Dandelion Root Extract (DRE) on Human
Melanoma Cell Viability. In order to investigate whether
Dandelion Root Extract (DRE) reduced cell viability in
human melanoma cells, the A375 cells were treated with
1, 2.5, and 5mg/mL concentrations of DRE. DRE was
found to reduce cell viability in a dose-dependent fashion,
over time, in A375 melanoma cells as was measured by
WST-1 assay. Based on metabolic activity of A375s, it was
conﬁrmed that treatment at 2.5mg/mL DRE resulted in
∼50% reduction in cell viability against control within4 Evidence-Based Complementary and Alternative Medicine
24 hours (Figure 1(a)). After cells were imaged with Hoechst
dye, it was found that by 48 hours there was a clear
induction of apoptosis at concentrations above 2.5mg/mL
(Figure 1(b)), as distinguished by brightly stained nuclei and
the morphological features of condensation and fragmen-
tation.
Using the eﬀective and subeﬀective doses, we sought to
conﬁrm that apoptosis in A375 cells was indeed induced,
using the Annexin-V binding assay. The assay conﬁrms that
by 48 hours the phosphatidyl serine has ﬂipped from the
innerleaﬂetoftheplasmamembranetotheouterleaﬂetafter
treatment with 2.5mg/mL DRE (Figure 1(c)).
3.2.EvaluationofDREToxicityonNormalHumanFibroblasts.
With DRE having proven its eﬃcacy in successfully killing
this aggressive, chemoresistant form of skin cancer, DRE
toxicity on normal cells had to be evaluated. Taraxacum
extracts have been used for centuries and therefore it is
assumed that normal cells are unaﬀected by it. Regard-
less, Normal Human Fibroblasts (NHFs) were used as a
normal counterpart to human melanoma cells to test this
assumption.DREwastreatedattheeﬀectiveandsubeﬀective
doses of DRE (1 and 2.5mg/mL). After a long exposure
of 96 hours, NHFs did not exhibit any reduction in cell
viability (Figure 2(a)), and this was further supported by the
lack of brightly stained, condensed and fragmented nuclei
(characteristic of apoptosis) when stained with Hoechst
dye (Figure 2(b)). Similarly, PBMCs (another normal cell
line) treated with DRE were not susceptible to apoptosis
induction after 48 hours of treatment (Figures 2(c) and
2(d)).
3.3. Analysis of Cell Death Pathways Employed by DRE.
To determine how apoptosis is being induced in A375
cells, we wanted to assess whether there was cell surface
death receptor-mediated induction resulted in caspase-8
activation. Logically, we ﬁrst chose a time point (24 hours)
prior to when we had observed apoptosis (48 hours) by
Hoechst staining with 2.5mg/mL DRE (Figures 1(a) and
1(b)). However, this proved to be too late and caspase-
8 activation occurred, cleaving the IETD-AFC substrate,
within 30 minutes of DRE treatment (Figure 3).
Considering early activation of a death receptor-mediat-
ed pathway, we wanted to then assess the eﬀect of DRE on
the mitochondria by observing polarization/depolarization
across the mitochondrial membrane using the JC-1 dye.
The JC-1 dye moves into the mitochondria and will only
aggregate if the mitochondrial membrane potential is main-
tained, as shown by red punctate marks. By 24 hours, the
eﬀective dose of 2.5mg/mL DRE indicated the dissipation in
the mitochondrial membrane potential, indicated by fewer
punctate marks, as a result of the dye’s inability to aggregate
in the mitochondria with lost potential (Figure 4).
In order to determine whether the ROS generation in
A375 melanoma cells was as a direct result of DRE or not,
mitochondria isolated from the A375 melanoma cells [18]
were treated with DRE at 1 and 2.5mg/mL concentrations.
Mitochondrial ROS was measured over 25 minutes for 2-
minute intervals. A steady increase in the levels of mitochon-
drial ROS was observed compared to untreated control. At 0
minutes (T = 0), there is a 2.5mg/mL DRE generated higher
levels of reactive oxygen species than 1mg/mL (data not
shown). However, over time both concentrations showed the
samerateofROSproductioncomparedtocontrol(Figure 5).
Following this we observed the levels of Bcl-2 antiapop-
totic protein from cells treated at 15 and 45 minutes. Bcl-2
levels are normally up-regulated in cancer cells as a means to
safeguard them from apoptosis induction; this protein is also
downstream of caspase-8. Though preliminary, we found
thattherewasreductioninthelevelsofBcl-2proteinearlyon
at the 2.5mg/mL dose, against the β-actin control (Figure 6).
3.4. Evaluating A375 Melanoma Cell Revival Posttreatment.
To ascertain the long-term eﬃcacy of DRE on chemo-resist-
ant melanoma, A375 cells were treated at 2.5 and 5mg/mL
for 72 hours before being replated in drug-free media and
incubated for 96 hours. The Trypan blue count after 96
hours shows a reduction in cell viability upon increasing
concentration. The viable cells counted also account for
membrane unpermeabilized apoptotic cells (Figure 7(a)),
and these apoptotic cells can be observed by Hoechst
staining (Figure 7(b)). In (Figure 7(b)), the apoptotic
nuclei can be clearly distinguished by the brightly stained
nuclei.
3.5. Eﬀect of DRE on G361 Human Melanoma Cells. To
further determine the eﬀect of DRE on other melanomas,
we used the G361 human melanoma cell line and treated
these cells for 72 hours at the same concentrations of DRE as
the A375s. These doses proved to be ineﬀective in reducing
cell viability and inducing apoptosis in G361 cells (data not
shown). Higher doses were then used and a response was
observed at a concentration of 10mg/mL (Figures 8(a) and
8(b)). In combination with the anti-type II diabetes drug
and metabolism interfering drug, metformin, these relatively
more resistant melanoma cells were sensitized to the eﬀects
of DRE even at lower doses of 5mg/mL (Figures 9(a) and
9(b)).
4. Discussion
Dandelion Root Extract (DRE) has thus far been used in
traditional medicine as a detoxifying agent for digestive
disorders, for lung, breast, and uterine tumours [2], and
most interestingly, to treat chronic diseases of the skin [4].
However, there has been little scientiﬁc advancement made
in this ﬁeld with regard to the eﬀect of dandelion root
extract on cancer, and even more so on chemoresistant,
human malignant melanoma skin cancer. Previous work
with Taraxacum has not provided much mechanistic detail
with regards to apoptosis induction, instead highlighting
its antioxidant and anti-inﬂammatory eﬀects. In this study
of human melanoma cells, we show that Dandelion Root
Extract (DRE) is more than a worthy chemopreventative, it
is fast-acting, nontoxic, and therefore speciﬁc in its targetingEvidence-Based Complementary and Alternative Medicine 5
3 2 1 0
DRE (mg/mL)
0
50
100
C
e
l
l
v
i
a
b
i
l
i
t
y
a
s
c
o
n
t
r
o
l
(
%
)
24hours
48hours
72hours
(a)
DRE 10mg/mL DRE 5mg/mL DRE 2.5mg/mL DRE 1mg/mL Control
15microns 15microns 15microns 15microns 15microns
(b)
DRE 2.5mg/mL DRE 1mg/mL Control
15microns 15microns 15microns
H
o
e
c
h
s
t
A
n
n
e
x
i
n
-
V
(c)
Figure 1:DeterminingthesensitivityofA375humanmelanomacellstoDRE(a)EﬀectofDREoncellviability.A375humanmelanomacells
were seeded on 96-well plates (∼1000cells/well) and treated at the indicated concentrations for 24, 48, and 72 hours. The WST-1 dye was
added to each well after every treatment period and incubated, as described in Section 2. Absorbances were read at 450nm. (b) Induction of
apoptosis by DRE. Typical apoptotic morphology was observed in A375 cells treated with DRE (0–10mg/mL concentrations) for 48 hours.
Cells were stained with Hoechst 33342 dye, before images were taken on a ﬂuorescence microscope. Brightly stained, condensed bodies
indicate apoptotic nuclei. (c) Conﬁrmation of apoptosis by Annexin-V binding assay. Cells treated at the eﬀective and subeﬀective doses
of 2.5 and 1mg/mL, respectively, for 48 hours were stained with Annexin-V Alexa Fluor (green) following which cells were imaged on a
ﬂuorescence microscope.
of human melanoma cancer cells, making it a valuable
chemotherapeutic. We have investigated the induction of
apoptosis in human malignant melanoma cells and observed
its long-term eﬀects in human melanoma cancer.
The WST-1 assay (the readings of which are returned
as a function of metabolic activity of mitochondrial
dehydrogenases) reported reductions in A375 cell viability in
a time- and dose-dependent manner upon DRE treatment6 Evidence-Based Complementary and Alternative Medicine
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Figure 2: Determining the toxicity of DRE on Normal Human Fibroblasts (NHFs) (a) Eﬀect of DRE on NHF cell viability. NHFs were
seeded on a 96-well plate (∼2000cells/well) and treated with DRE at the indicated concentrations for 96 hours. The WST-1 dye was added
to each well after the 96-hour treatment period and incubated as described in Section 2. Absorbances were read at 450nm. (b) Nontoxic
eﬀect of DRE on NHFs. NHFs were treated with DRE at the indicated concentrations for 96 hours. Cells were stained with Hoechst 33342
dye and imaged ona ﬂuorescence microscope, as described in Section 2 (c) Eﬀect of DRE on peripheral mononuclear blood cells (PBMCs).
PBMCs were treated at the indicated concentrations for 48 hours before being stained with Hoechst 33342 dye and imaged on a ﬂuorescence
microscope. (d) Nontoxic eﬀect of DRE on PBMCs. PBMCs treated in Figure 2(c) were quantiﬁed by manual counting of brightly stained
apoptotic nuclei.
(Figure 1(a)). By 48 hours, human melanoma A375 cells
uncharacteristically showed susceptibility to apoptosis
induction by DRE (Figure 1(b)), displaying morphological
features of condensed and fragmented nuclei—typical of
apoptotic cells. Based on cell viability and observation of
extent of apoptosis by 48 hours, we established the eﬀective
dose as 2.5mg/mL. Given that DRE has traditionally been
used naturopathically for a variety of ailments, we assume
that it would be relatively nontoxic to healthy cells. Our
results show that the Normal Human Fibroblasts (NHFs)
(which were treated at a low population doubling where
NHFs have the best proliferation rate) and Peripheral Blood
Mononuclear Cells remained unaﬀected and healthy after a
96-hourand48-hourexposuretoDRE,respectively(Figures
2(a)–2(d)).
Dandelion root extract has been resolved into com-
ponents using chromatography techniques [6]; however,
singular components themselves may not be enough to
trigger a chemotherapeutic response in a chemoresistant
cancer. Components may require each other to work in
unison or even synergy, which is possibly why they have been
eﬀective as extracts in traditional medicines. With one of the
triterpene components of DRE, Lupeol, Hata et al. observed
a decrease in mouse melanoma diﬀerentiation [7]. This
study has been supported by a two-stage skin carcinogenesis
mouse model showing antiproliferative and chemopreventa-
tive activity of this compound [19]. However, initial in vivo
studies with Taraxacum japonicum, conducted by Takasaki et
al., concluded that it was the taraxasterol component that
was the worthy cancer chemopreventative [9]. Though the
extract is constituted of a myriad of compounds, we wanted
todeterminetheresultantmechanisticeﬀectofthecombined
components in speciﬁcally killing human melanoma cells.
Caspase-8 activation results from the binding of ligands
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Figure 3: Caspase-8 activity in DRE-treated A375 cells. A375 cells
were treated at 2.5mg/mL for the indicated periods of time. Cells
were collected and incubated with caspase-8 IETD-AFC substrate
for an hour before being read on a spectroﬂuorometer as described
in Section 2. Statistical analysis was performed using the GraphPad
Prism 5.0; ∗denotes a P-value <.05; ∗∗denotes a P-value <.01.
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Figure 4: Dissipation of the mitochondrial membrane potential
in A375 cells. A375 cells were seeded on coverslips and treated
with DRE for 24 hours. The JC-1 was then added and cells
were incubated for 1 hour, before being imaged on a ﬂuorescent
microscope, as described in Section 2. Punctate marks indicate
healthy mitochondria.
on the cell surface [20]. Fas-receptor-mediated apoptosis
would result in recruitment and conversion of pro-caspase-
8 to active caspase-8. In this study, we observed the rapid
activation of caspase-8 enzyme in A375 cells, and this is
corroborated by a previous report by Ariza et al. stating that
thesecellsdoexpresstheFasreceptor,thusstrengtheningour
theory that an extrinsic apoptotic pathway is activated [21].
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Figure 5: Assessing levels of DRE-induced ROS generation in
A375 mitochondria. Mitochondria were isolated from A375 cells as
described in Section 2.
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Figure 6: Reduction in Bcl-2 levels after treatment over time with
DRE. A375 cells were treated with 2.5mg/mL DRE for 15 and 45
minutes. Equal amounts of protein (20μg) were separate using
SDS-PAGE. Western blotting with anti-Bcl-2 antibody assessed
Bcl-2 levels. Equal protein loading was conﬁrmed by β-actin
immunoblotting.
Judging by the diminished activity of the mitochondrial
dehydrogenases (Figure 1(a)), we also visualized dissipation
of the mitochondrial membrane potential at 24 hours of
treatment using JC-1. This indicates that the mitochondria
is depolarized early on, and this in turn agrees with the
induction of apoptosis that we observe at 48 hours of
treatment, following the dissipation. Direct mitochondrial
destabilizationalsooccurreduponDREtreatmentindicating
that DRE action is not only cell death receptor-mediated,
but that its eﬀect on the mitochondria may not be purely
resultant,butaconsequenceofdirectmitochondriatargeting
and even possible cross talking between the extrinsic and
intrinsic pathways. More importantly, an increase in ROS
production indicates prooxidant behaviour of DRE on can-
cer cell mitochondria, which is contrary to the antioxidant
convictions of traditional medicine and previous studies on8 Evidence-Based Complementary and Alternative Medicine
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Figure 7: Determining A375 cell revival after DRE-treatment. (a)
Negatively stained A375 cell count after DRE-treatment. A375 cells
were treated with DRE, at the indicated concentrations, for 72
hours, following which they were replated in fresh drug-media and
incubated for 96 hours as described in Section 2. Negatively stained
cells were collected and counted using Trypan blue. Statistical
analysis was performed using the GraphPad Prism 5.0; ∗denotes a
P-value <.05. (b) Continued apoptosis induction in A375 cells after
DRE-treatment. A375 cells were treated with DRE at the indicated
concentrationsfor72hours,asdescribedinSection 2After96hours
of incubation in drug-free media, cells were stained with Hoechst
33342 dye and imaged on a ﬂuorescence microscope.
Taraxacum extracts citing reductions in NO, ROS, RNS,
and COX-2 [10, 11] in mouse macrophages. This duality in
Taraxacum’s operation may depend on the cell’s nature—
normal versus cancerous—further underlining Taraxacum’s
ability to distinguish between these cells.
With early activation of caspase-8 induction, we had also
observed, in a preliminary study, a decrease in the levels
of Bcl-2 protein within 45 minutes compared to control
(Figure 6). In normal cells, keratinocytes, which regulate
melanocytes, promote Bcl-2 expression [22]. Though the
role of Bcl-2 expression in melanoma remains controversial
in terms of tumourigenesis initiation, the cells are sure to
exploit the high levels of endogenous Bcl-2 to survive [1].
Previous studies have already shown that antisense silencing
of Bcl-2 sabotages melanoma survival, facilitating eﬀective
melanoma chemotherapy [23].
There are two main points that must be stated here:
ﬁrstly, that noncancerous cells are unaﬀected by DRE
treatment, and secondly, melanoma cells retain the signals
to commit suicide long after DRE has been removed from
the system. These cells correspond to those which remain
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Figure 8: Eﬀect of DRE on G361 human melanoma cells. (a)
Eﬀect of DRE on G361 cell viability. G361 human melanoma cells
were seeded on 96-well plates (∼3000cells/well) and treated at
the indicated concentrations for 72 hours. The WST-1 dye was
added to each well after every treatment period and incubated,
as described in Section 2. Absorbances were read at 450nm. (b)
Induction of apoptosis in G361 cells by DRE. Typical apoptotic
morphology was observed in G361 cells treated with DRE at
10mg/mL concentrations for 72 hours. Cells were stained with
Hoechst 33342 dye, before images were taken on a ﬂuorescence
microscope. Brightly stained, condensed bodies indicate apoptotic
nuclei.
nonapoptotic after the initial 96-hour treatment with DRE.
The cell count in Figure 7(a) represents negative Trypan blue
staining which indicates membrane unpermeabilized cells-
viable and also apoptotic cells. Hoechst images corroborate
the Trypan counts by revealing brightly stained nuclei after
96hoursmostlyat5mg/mLDRE.Thesecells,therefore,have
retained the signals to commit suicide long after the drug
has been removed, making it a worthy chemotherapeutic
(Figure 7(b)).
Upon comparison of A375 melanoma with G361, we
found that the latter did not respond to the same doses andEvidence-Based Complementary and Alternative Medicine 9
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Figure 9: Combinatorial treatment of metformin and DRE on relatively resistant G361 cells. (a) Cell viability of relatively resistant G361
cells. G361 human melanoma cells were seeded on 96-well plates (∼3000cells/well) and treated at the indicated concentrations of DRE and
4mM metformin for 72 hours. The WST-1 dye was added to each well after every treatment period and incubated, as described in Section 2.
Absorbances were read at 450nm. Statistical analysis was performed using the GraphPad Prism 5.0; ∗∗denotes a P-value <.05 compared
to untreated control without metformin; ∗∗∗denotes a P-value <.0005 compared to untreated control without metformin; ##denotes a P-
value <.05 compared to 5mg/mL DRE treatment without metformin; VV denotes a P-value <.05 compared to 10mg/mL treatment without
metformin. (b) Induction of apoptosis in metformin-treated G361 cells by DRE. Typical apoptotic morphology was observed in G361 cells
treated with DRE starting at 5mg/mL concentrations for 72 hours. Cells were stained with Hoechst 33342 dye, before images were taken on
a ﬂuorescence microscope. Brightly stained, condensed bodies indicate apoptotic nuclei.
only started to respond, though minimally, to DRE at much
higher concentrations (10mg/mL)—about four times the
eﬀective concentration for A375 (Figures 8(a) and 8(b)).
Since WST-1 assay showed increased susceptibility of only
A375 to DRE (Figure 1(a)), measured at the mitochondrial
level, diﬀerences between these cell lines could highlight the
mechanism by which DRE is acting to induce programmed
cell death in one cell line (A375) while being resisted by
the second (G361). According to Su et al., in a microarray
study comparing diﬀerent melanoma cell lines for gene
expression, it was found that G361 and A375s have varying
levels of antioxidant and anti- and pro-apoptotic genes that
are expressed [24]. For example, at basal conditions, the
antioxidant, prosurvival gene, ATOX1, is up-regulated, and
the pro-apoptotic gene, CASP4, is down-regulated in G361,
but is uninduced in A375 in both cases. Quantiﬁcation of
gene expression using qRT-PCR, by Su et al., showed signiﬁ-
cant up-regulation in 3 antiapoptotic genes (PHB, PPP2R1B,
and OPA) and the antioxidant gene for glutathione reductase
(GSR). We could speculate that a combination of these
factors could contribute to why G361 does not respond to
DRE treatment, and by eliminating these factors, we could
possibly determine how DRE might therefore act in A375
human melanoma cells.
With the relatively resistant G361 cells not responding
to DRE treatment, we used the anti-type-II diabetes drug,
metformin, to sensitize the cells. The energy metabolism of
cancer cells being diﬀerent from normal cells potentiates
this diﬀerence as a point of speciﬁc vulnerability [14].
Metformin acts as a metabolism interfering compound that10 Evidence-Based Complementary and Alternative Medicine
debilitates cancer cells, and the case of G361-resistant
melanoma cells, combining DRE with metformin reduces
cell viability at even lower doses (Figures 9(a) and 9(b)).
Up to date work on human melanoma cells treated with
metformin has been unprecedented. Figure 9(a) shows that
cell viability is reduced with metformin treatment alone.
However, morphologically, under the microscope, we found
that the number of cells was unaﬀected by metformin
treatment alone (1mM–8mM). This means cell viability
reduction was due to metformin inhibiting some of the
metabolic enzymes in these cells, but without aﬀecting the
cell number (data not shown). In all other cases, there was
alwaysacorrelationwiththeWST-1activityandviability/cell
number.
The dandelions that we had collected for this investiga-
tion were harvested in the month of May. Previous studies
with Canadian dandelion have stated that during Autumn
senescence, there is a accumulation of amino acids in the
roots, but the levels of amino acids diminish in Spring,
resulting in ﬂuctuations between asparagine and glutamine
across the seasons [25]. This is indicative that our extract is
not primarily amino acid based.
As mentioned before, various components like Lupeol
have been considered as chemopreventatives for cancer.
Components of DRE include sesquiterpenes (derivatives of
germacranolide, eudesmanolide, and guaianolide), diﬀerent
triterpenes like taraxasterol—their hydroxy derivatives and
their acetates—phenolics compounds (such as chicoric acid,
vanillic acid, p-hydroxyphenylacetic acid, p-hydroxybenzoic
acid, syringic acid, caﬀeic acid, chlorogenic acid, and ferulic
acid), and coumarins (scopoletin, esculetin, and umbellif-
erone) [26]. We are yet to determine the eﬀect of each of
the individual components (such as the family of triterpene
alcohols and phenolic acids—found in the roots—and
cinnamic acids, ﬂavinoids and coumarins—that are found
in the leaves) [27] but we believe that the compounds in
DRE most likely work in synergy with each other to produce
the aforementioned resultant eﬀect.We have performedhigh
performance liquid chromatography (HPLC) with our water
soluble DRE and compared it to a commercially available
DRE. Both extracts produced similar proﬁles (data not
shown).Wehavepreviouslyperformedproteasedigestionon
DRE and found that it did not have any eﬀect on its activity
on cancerous cells. In this study, we are narrowing on the
therapeuticpotentialofdandelionrootextractratherthanits
caliber as a prophylactic agent. We believe that this nontoxic
extract can undergo precipitous translation from bench top
to bedside, with dandelion products that are already com-
mercially available in the form of tea and supplements. Tra-
ditional therapeutics have provided us a new scope for har-
nessingthepotentialofnaturalextractsinmodernmedicine;
the eﬃcacy of DRE is only fully being realized now as a
chemotherapeutic against aggressive chemoresistant cancers.
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